Groundbreaking gene therapy trial allows 5 children born deaf to hear
The patients in the trial suffered from a genetic condition called autosomal recessive deafness 9 (DFNB9), which is caused by a mutation in a gene called OTOF
Combo therapy trial achieves 94% remission rate for Hodgkin’s lymphoma
Hodgkin Lymphoma is a relatively rare kind of cancer that affects the lymph nodes
Lung cancer pill drastically cuts risk of death after surgery
The study was the result of a 682-patient trial that included participants diagnosed with non-small cell lung cancer